2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics 2008 Barcelona - European Society of Human Genetics

24.08.2013 Views

Molecular and biochemical basis of disease mately 56 mutations have been described in the CYP17A1 gene . We present the molecular characterization of two novel mutations in this gene in a mexican-mestizo 46,XY female with CAH and severe hypertension who does not respond to treatment . Gene sequence revealed a compound heterozygous (K110X/ R362H) leading to a complete lack of enzyme activity . The patient was heterozygote for four SNPs . We suggest that these polymorphisms could be related to the failure of blood pressure treatment . We propose that all DSD patients require a multidisciplinary team to determine the etiology and orient the therapeutic approach to minimized medical, psychological and social complications . P05.031 molecular genetic analysis of cYP2D6 gene and used methods E. Flodrova1,2 , A. Žourková3,2 , T. Kašpárek3 , J. Juřica2 , R. Gaillyová1,2 ; 1Department of Medical Genetics, University Hospital, Brno, Czech Republic, 2 3 Faculty of Medicine, Masaryk University, Brno, Czech Republic, Department of Psychiatry, University Hospital, Brno, Czech Republic. The cytochrome CYP2D6 is enzyme responsible for metabolisation of many commonly used drugs such as tricyclic antidepressants, neuroleptics, beta blockers and antiarhythmics . CYP2D6 is localized together with pseudogenes CYP2D7 and CYP2D8 at chromosome 22 and it is highly polymorphic . The polymorphisms leads to different individual responses following drug administration and increased risk of adverse reactions or the lack of the therapeutic response . According to the enzymatic activity the population has been grouped as - poor metabolizers, intermediate metabolizers, effective metabolizers, ultrarapid metabolizers. There are studied influences of polymorphisms to the antidepressants treatment for a long time in Department of Medical Genetics and Department of Psychiatry . Methods such as direct sequencing and agarose electroforesis are subsequently combinated with more modern, faster and more effective method - Real-Time PCR and High Resolution Melting using the Light Cycler 480 System . Recently we can detect the most frequent null alleles 3* 4* 6* 7* and 8* using the specific fluorescent labeled probes. Up to 99% of poor metabolizers in the Caucasian population can be detected with genetic testing for only 5 alleles (plus allele 5*, which can be detected by using the Sybr green) . The High Resolution Melting has been performed for the most frequent SNP´s in CYP2D6 gene . Heterozygous samples are readily distinguished from homozygous and wild-type samples with used dyes . This paper provides an overview of current technologies available for assessing polymorphisms in Department of Medical Genetics . Supported by research project MSM 0021622404 (2005 - 2011) P05.032 the clinical Use of Fluorescent Repeat-Primed PcR Assay in the Diagnosis of myotonic Dystrophy type 1 E. L. Spriggs 1,2 , P. Frosk 1 , R. Ray 1 ; 1 Molecular Diagnostic Laboratory, Diagnostic Services of Manitoba, Winnipeg, MB, Canada, 2 Departments of Biochemistry & Medical Genetics and Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, Canada. Some trinucleotide repeat expansion disorders require Southern blot analysis to confirm the presence or absence of a large repeat expansion adding days to turnaround time . Cagnoli et al . (2004) successfully applied the use of fluorescent repeat-primed PCR (RPPCR) method to differentiate between patients who are homozygous for a normal-sized allele and those who are heterozygous for a very large expansion for Friedreich ataxia and spinocerebellar ataxia types 10 and 12 . Using a slight modification of this RPPCR method, we were able to consistently detect the presence of large repeat expansions in the 3’UTR of the DMPK gene, the mutation underlying myotonic dystrophy type 1 . To assess the validity of this assay in a clinical setting, all 63 patient samples and 9 quality assurance samples received over 18 months for myotonic dystrophy type 1 were analyzed by the usual “gold standard” method as well as by RPPCR . In the standard method, the number of CTG repeats is determined using fluorescent PCR followed by capillary electrophoresis . For a situation where only one normal-sized repeat is observed or two normal-sized repeats that are only one trinucleotide repeat apart in size, the sample is further tested by Southern blot analysis . A review of all data showed 100% correlation between the results obtained from the “gold standard” and RPPCR . As RPPCR can only show the presence of the expansion and cannot provide information regarding size of the expanded allele, Southern blot must be pursued for RPPCR-positive patients . For RPPCR-negative patients, Southern blot analysis is unnecessary . P05.033 Human miRNAs on chromosome 21 are differentially expressed in Down syndrome fetal hearts F. Fabbrini, A. Izzo, R. Negri, R. Cicatiello, A. Ferraro, R. Genesio, A. Conti, L. Nitsch; University Federico II, Napoli, Italy. We previously demonstrated dosage-dependent upregulation of chromosome 21 (Hsa21) genes and dysregulation of mitochondrial and ECM genes in heart tissues of Down syndrome (DS) fetuses . Some of these dysregulated genes might be responsible for the DS cardiac phenotype, but it is evident that also other functional non-coding sequences, such as miRNAs, might play an important role . MiRNAs are highly expressed in the heart and regulate cardiac development and function . Five miRNAs, according to Sanger miRBase, are on Hsa21: miR-99a, miR-125b, let-7c, miR-155 and miR-802 . Nothing is known about their expression in trisomic tissues . We evaluated by qRT-PCR the expression of Hsa21 miRNAs in heart tissues from DS fetuses and controls . We found that miR-99a, miR- 125b, let-7c and miR-155 were expressed in 20-22 weeks fetal heart . MiR-802 was not expressed . MiR-99a, miR-155 and let-7c were overexpressed in trisomic hearts, whereas miR-125b was normoregulated . Target genes of upregulated miRNAs were obtained by merging Pic- Tar, TargetScan and MiRanda prediction lists . As miRNAs could affect protein expression by either interfering with RNA translation or promoting mRNA degradation, we evaluated the mRNA expression of target genes of overexpressed miRNAs by using the data set of our previous study . Seventeen targets of miR-99a, 12 of miR-155 and 15 of let-7c were expressed in fetal heart and downregulated in trisomic samples . Target genes possibly involved in DS phenotype were found such as SLC25A4, let-7c target, downregulated in DS hearts and involved in mitochondrial function, and CYP26B1, miR-99a target, showing a dosage-dependent effect on ventricular septal defects . P05.034 study of folate genes alteration CBS 844ins68 and MTR A2756G as maternal risk factor of Down syndrome among iranian cases M. T. Mirgani, A. Aleyasine; National Institue for Genetic Engineering and Biotechnology, Tehran, Islamic Republic of Iran. Down syndrome is the most common chromosomal abnormality occured 1 in 700 live birth . Abnormal segregation of chromosome 21 in meiosis is the cause of trisomy 21 . Common polymorphisms in enzymes coding genes in folic acid pathway have been suggested to play role in etiology of chromosome 21 nondisjunction . In this study, the role for 844ins68 polymorphism in cystathionine beta synthase (CBS) gene and A2756G polymorphism in methionine synthase gene (MTR) in folic acid pathway has been investigated as maternal genetic risk factor of Down syndrome among Iranian patients . CBS 844Ins68 polymorphism is a 68 bp insertion in exon 8 of this gene and MTR A2756G polymorphism causes an A>G transition at 2756 bp . We have studied 93 mothers having DS children and 116 aged matched control mothers for the frequency of above polymorphisms using RFLP PCR analysis . Genomic DNA was extracted from blood Leukocytes by salting out procedure . Frequencies of 844Ins68 polymorphism were 8 (8 .6%) in mother cases and 18 (15 .5%) in control mothers with no homozygousity in both groups . Frequency of A2756G polymorphism was observed as AA in 56 (60 .2%) AG in 33 (35 .5%) and GG in 4 (4 .3%) in cases mothers and were 56%, 35 .3% and 10% among control mothers respectively . Statistical analysis showed no association between 844ins68 and A2756G polymorphisms and risk of Down syndrome in Iranian mothers (P-value for 844Ins68 and A2756G were 0 .146 and 0 .451 respectively) . Combination of these polymorphisms also have no effect on risk of Down syndrome’s mother (P-Value was 0 .216 ) .

Molecular and biochemical basis of disease P05.035 supporting the appropriate ordering of genetic laboratory tests in the UK healthcare workforce C. Barker, C. Bennett, C. Cooley, P. Farndon; NHS National Genetics Education and Development Centre, Birmingham, United Kingdom. To address an increased need to promote the clinically appropriate and equitable ordering of genetic laboratory tests in the UK, the NHS National Genetics Education and Development Centre is working to raise understanding and knowledge of genetics in the UK healthcare workforce for non-genetics specialists . The Centre identified the key knowledge and attitudes required to encourage appropriate ordering of genetic laboratory tests as part of a wider project to integrate genetic skills into clinical practice, job planning, evaluation, education and training . The knowledge and attitudes identified allow healthcare staff to recognise where genetic tests will inform clinical management within the limits of their role and where referral is appropriate . Healthcare staff will also be equipped to recognise any social, ethical or legal implications in ordering the genetic laboratory test . To integrate these skills into clinical practice, the Centre has targeted health professionals for whom genetics is highly relevant and is working with these groups and other professional bodies to identify how genetics affects their clinical practice . Using this information, the Centre is creating tools allowing healthcare staff to recognise where genetics impacts on their clinical practice . For example, relevant case scenarios allow healthcare staff to draw parallels with their own clinical practice . These tools are further supported by the Centre through the provision of education and training support and learning and teaching resources . It is envisaged that this work will lead to more appropriate and equitable ordering of genetic tests and ultimately the enhancement of patient care . P05.036 Vascular type of Ehlers-Danlos syndrome: Evidences for a stochastic effect of COL3A1 haploinsufficiency A. Plancke1 , M. Holder-Espinasse2 , V. Rigau3 , C. Rene1 , M. Taulan1 , B. Catteau2 , R. Sfeir2 , S. Coopman2 , N. Pallares-Ruiz1 , S. Manouvrier-Hanu2 , M. Claustres1 , P. Khau Van Kien1 ; 1 2 CHU Montpellier/INSERM U827, Montpellier, France, CHRU de Lille, Lille, France, 3CHU Montpellier, Montpellier, France. Mutations that confer an unusual pattern of inheritance in a gene related to a well known genetic disease can sometimes highlight a particular mechanism useful to correlate genotype to phenotype . Here we describe a case of recessive Ehlers-Danlos syndrome (EDS) in a young girl of asymptomatic and related parents (uncle-niece) . She exhibited: atrophic scars, extensive bruising, joint hypermobility and died at 12 years-old from an extreme intestinal fragility . According to the Villefranche nosology, she fulfilled the criteria of EDS vascular type for laboratory testing . Total sequencing of COL3A1 cDNA (obtain form skin cultured fibroblasts) identified an homozygous nucleotide duplication (c .479_480dupT) resulting in a premature termination codon (p .Val160fsX46) . Studies in genomic DNA showed that this mutation in exon 5 of the COL3A1 gene was inherited from each parent . As expected, the expression analysis (RT-PCR, quantitative-PCR, Immunohistochemistry, WB) showed a strong mRNA decay, which results in an absence of type III collagen in the proband . This case, shows that a deficit in collagen III is viable in early childhood in Man. Here, the expected COL3A1 haploinsufficiency in her asymptomatic ascendants did not lead to the severe clinical manifestations of EDS vascular type cause by haploinsufficiency of one allele as described in the literature . This case provides evidences for a stochastic effect of COL3A1 haploinsufficiency in Man with (a) modifying factor(s), which remains to be identified. P05.037 Early myoclonic encephalopathy caused by a disruption of the Neuregulin-1 receptor ErbB4 H. Van Esch1 , B. Ceulemans2 , J. Vermeesch1 , K. Devriendt1 , L. Backx1 ; 1 2 Center for Human Genetics, Leuven, Belgium, Rehabilitation and Epilepsy Centre for Children and Youth, Pulderbos, Belgium. The tyrosine kinase receptor ErbB4 (erythroblastic leukemia viral oncogene homolog 4) plays a crucial role in numerous neurobiological processes in the developing and adult brain . One of the most important and well-studied ligands of ErbB4 is Neuregulin-1 (NRG1) and it was shown that NRG1-ErbB4 signaling is essential for neurobiological processes like neurogenesis, migration, synaptic plasticity and differentiation of neurons and glia . Moreover, recent molecular genetics studies implicate ErbB4 in the pathophysiology of schizophrenia . However, the phenotypic consequences of haploinsufficiency of ErbB4 are not known, since no coding mutations have been identified until now. Here, we present a patient with early myoclonic encephalopathy and profound psychomotor delay with a de novo reciprocal translocation t(2;6)(q34;p25 .3), disrupting the ErbB4 gene . This patient represents the first case of haploinsufficiency for one of the ErbB family members of tyrosine kinase receptors . P05.038 mutation analysis of epidermolysis bullosa in the czech Republic B. Jerabkova 1,2 , L. Fajkusova 1,2 , H. Buckova 3,2,4 , K. Vesely 5,6 , R. Gaillyova 7,2 ; 1 Centre of Molecular Biology and Gene Therapy, Faculty Hospital Brno, Brno, Czech Republic, 2 Masaryk University Brno, Brno, Czech Republic, 3 Department of Pediatric Dermatology of 1st Pediatric Clinic, Faculty Hospital Brno, Brno, Czech Republic, 4 Institute of Medical Postgraduate Studies Prague, Prague, Czech Republic, 5 1st Institute of Pathological Anatomy, St. Ann´s Hospital, Brno, Czech Republic, 6 Medical Faculty of Masaryk University Brno, Brno, Czech Republic, 7 Department of Clinical Genetics, Faculty Hospital Brno, Brno, Czech Republic. Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of heritable skin disorders . It is characterised by skin blistering and mucous membrane . EB has been divided into three major categories based on the level of blister formation in dermal-epidermal junction zone . EB is diagnosed by evaluation of clinical findings, by transmission electron microscopic examination of a skin biopsy and immunohistochemical mapping of protein components of dermal-epidermal junction zone from a skin biopsy . Molecular-genetic diagnostics of EB was initiated in 2004 . Dystrophic EB (EBD) is caused by mutations in the collagen type VII (COL7A1), which consists of 118 exons . EB simplex (EBS) is caused by mutations in the keratin 5 (KRT5), which consists of 9 exons and keratin 14 (KRT14), which consists of 8 exons . DNA from EB patients and their relatives were screened for mutations in COL7A1, KRT5 and KRT14 genes . Analysis was performed using PCR, denaturing high performance liquid chromatography, high resolution melting analysis and direct sequencing . We could identify KRT5 or KRT14 dominant mutations in 11 out of 18 EBS families . As regards 27 EBD probands, we revealed disease causative mutations in 16 patients and screening of COL7A1 is in progress . Prenatal diagnosis of one pregnancy in family with occurrence of EBS predicted the fetus being normal and subsequently a healthy child was born . Determination of EB at the level of DNA has important implication for final confirmation of diagnosis, possibility of genetic counselling and early prenatal diagnosis . This work was supported by IGA MH NR9346-3 . P05.039 Erythropoietic protoporphyria in a czech family caused by a new 84G>A (W28X) mutation in the ferrochelatase gene J. Prochazkova1 , J. Sperl2 , S. M. Farrag1 , L. Barnincova1 , J. Spicak2 , P. Martasek1 ; 1 2 1st School of Medicine, Charles University, Prague, Czech Republic, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Erythropoietic protoporphyria (EPP) is a disorder with autosomal dominant inheritance caused by partial deficiency of ferrochelatase (FECH). Ferrochelatase is the ultimate enzyme of heme biosynthesis . EPP is characterized by excess accumulation of protoporphyrin, particularly

Molecular and biochemical basis <strong>of</strong> disease<br />

P05.035<br />

supporting the appropriate ordering <strong>of</strong> genetic laboratory tests<br />

in the UK healthcare workforce<br />

C. Barker, C. Bennett, C. Cooley, P. Farndon;<br />

NHS National <strong>Genetics</strong> Education and Development Centre, Birmingham,<br />

United Kingdom.<br />

To address an increased need to promote the clinically appropriate<br />

and equitable ordering <strong>of</strong> genetic laboratory tests in the UK, the NHS<br />

National <strong>Genetics</strong> Education and Development Centre is working to<br />

raise understanding and knowledge <strong>of</strong> genetics in the UK healthcare<br />

workforce for non-genetics specialists .<br />

The Centre identified the key knowledge and attitudes required to encourage<br />

appropriate ordering <strong>of</strong> genetic laboratory tests as part <strong>of</strong> a<br />

wider project to integrate genetic skills into clinical practice, job planning,<br />

evaluation, education and training . The knowledge and attitudes<br />

identified allow healthcare staff to recognise where genetic tests will<br />

inform clinical management within the limits <strong>of</strong> their role and where<br />

referral is appropriate . Healthcare staff will also be equipped to recognise<br />

any social, ethical or legal implications in ordering the genetic<br />

laboratory test .<br />

To integrate these skills into clinical practice, the Centre has targeted<br />

health pr<strong>of</strong>essionals for whom genetics is highly relevant and is working<br />

with these groups and other pr<strong>of</strong>essional bodies to identify how<br />

genetics affects their clinical practice .<br />

Using this information, the Centre is creating tools allowing healthcare<br />

staff to recognise where genetics impacts on their clinical practice . For<br />

example, relevant case scenarios allow healthcare staff to draw parallels<br />

with their own clinical practice . These tools are further supported<br />

by the Centre through the provision <strong>of</strong> education and training support<br />

and learning and teaching resources .<br />

It is envisaged that this work will lead to more appropriate and equitable<br />

ordering <strong>of</strong> genetic tests and ultimately the enhancement <strong>of</strong><br />

patient care .<br />

P05.036<br />

Vascular type <strong>of</strong> Ehlers-Danlos syndrome: Evidences for a<br />

stochastic effect <strong>of</strong> COL3A1 haploinsufficiency<br />

A. Plancke1 , M. Holder-Espinasse2 , V. Rigau3 , C. Rene1 , M. Taulan1 , B. Catteau2<br />

, R. Sfeir2 , S. Coopman2 , N. Pallares-Ruiz1 , S. Manouvrier-Hanu2 , M.<br />

Claustres1 , P. Khau Van Kien1 ;<br />

1 2 CHU Montpellier/INSERM U827, Montpellier, France, CHRU de Lille, Lille,<br />

France, 3CHU Montpellier, Montpellier, France.<br />

Mutations that confer an unusual pattern <strong>of</strong> inheritance in a gene<br />

related to a well known genetic disease can sometimes highlight a<br />

particular mechanism useful to correlate genotype to phenotype . Here<br />

we describe a case <strong>of</strong> recessive Ehlers-Danlos syndrome (EDS) in<br />

a young girl <strong>of</strong> asymptomatic and related parents (uncle-niece) . She<br />

exhibited: atrophic scars, extensive bruising, joint hypermobility and<br />

died at 12 years-old from an extreme intestinal fragility . According to<br />

the Villefranche nosology, she fulfilled the criteria <strong>of</strong> EDS vascular type<br />

for laboratory testing . Total sequencing <strong>of</strong> COL3A1 cDNA (obtain form<br />

skin cultured fibroblasts) identified an homozygous nucleotide duplication<br />

(c .479_480dupT) resulting in a premature termination codon<br />

(p .Val160fsX46) . Studies in genomic DNA showed that this mutation<br />

in exon 5 <strong>of</strong> the COL3A1 gene was inherited from each parent . As<br />

expected, the expression analysis (RT-PCR, quantitative-PCR, Immunohistochemistry,<br />

WB) showed a strong mRNA decay, which results in<br />

an absence <strong>of</strong> type III collagen in the proband .<br />

This case, shows that a deficit in collagen III is viable in early childhood<br />

in Man. Here, the expected COL3A1 haploinsufficiency in her<br />

asymptomatic ascendants did not lead to the severe clinical manifestations<br />

<strong>of</strong> EDS vascular type cause by haploinsufficiency <strong>of</strong> one allele<br />

as described in the literature . This case provides evidences for a stochastic<br />

effect <strong>of</strong> COL3A1 haploinsufficiency in Man with (a) modifying<br />

factor(s), which remains to be identified.<br />

P05.037<br />

Early myoclonic encephalopathy caused by a disruption <strong>of</strong> the<br />

Neuregulin-1 receptor ErbB4<br />

H. Van Esch1 , B. Ceulemans2 , J. Vermeesch1 , K. Devriendt1 , L. Backx1 ;<br />

1 2 Center for <strong>Human</strong> <strong>Genetics</strong>, Leuven, Belgium, Rehabilitation and Epilepsy<br />

Centre for Children and Youth, Pulderbos, Belgium.<br />

The tyrosine kinase receptor ErbB4 (erythroblastic leukemia viral oncogene<br />

homolog 4) plays a crucial role in numerous neurobiological<br />

processes in the developing and adult brain . One <strong>of</strong> the most important<br />

and well-studied ligands <strong>of</strong> ErbB4 is Neuregulin-1 (NRG1) and it<br />

was shown that NRG1-ErbB4 signaling is essential for neurobiological<br />

processes like neurogenesis, migration, synaptic plasticity and differentiation<br />

<strong>of</strong> neurons and glia . Moreover, recent molecular genetics<br />

studies implicate ErbB4 in the pathophysiology <strong>of</strong> schizophrenia . However,<br />

the phenotypic consequences <strong>of</strong> haploinsufficiency <strong>of</strong> ErbB4 are<br />

not known, since no coding mutations have been identified until now.<br />

Here, we present a patient with early myoclonic encephalopathy and<br />

pr<strong>of</strong>ound psychomotor delay with a de novo reciprocal translocation<br />

t(2;6)(q34;p25 .3), disrupting the ErbB4 gene . This patient represents<br />

the first case <strong>of</strong> haploinsufficiency for one <strong>of</strong> the ErbB family members<br />

<strong>of</strong> tyrosine kinase receptors .<br />

P05.038<br />

mutation analysis <strong>of</strong> epidermolysis bullosa in the czech<br />

Republic<br />

B. Jerabkova 1,2 , L. Fajkusova 1,2 , H. Buckova 3,2,4 , K. Vesely 5,6 , R. Gaillyova 7,2 ;<br />

1 Centre <strong>of</strong> Molecular Biology and Gene Therapy, Faculty Hospital Brno, Brno,<br />

Czech Republic, 2 Masaryk University Brno, Brno, Czech Republic, 3 Department<br />

<strong>of</strong> Pediatric Dermatology <strong>of</strong> 1st Pediatric Clinic, Faculty Hospital Brno, Brno,<br />

Czech Republic, 4 Institute <strong>of</strong> Medical Postgraduate Studies Prague, Prague,<br />

Czech Republic, 5 1st Institute <strong>of</strong> Pathological Anatomy, St. Ann´s Hospital,<br />

Brno, Czech Republic, 6 Medical Faculty <strong>of</strong> Masaryk University Brno, Brno,<br />

Czech Republic, 7 Department <strong>of</strong> Clinical <strong>Genetics</strong>, Faculty Hospital Brno, Brno,<br />

Czech Republic.<br />

Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous<br />

group <strong>of</strong> heritable skin disorders . It is characterised by skin blistering<br />

and mucous membrane . EB has been divided into three major<br />

categories based on the level <strong>of</strong> blister formation in dermal-epidermal<br />

junction zone .<br />

EB is diagnosed by evaluation <strong>of</strong> clinical findings, by transmission<br />

electron microscopic examination <strong>of</strong> a skin biopsy and immunohistochemical<br />

mapping <strong>of</strong> protein components <strong>of</strong> dermal-epidermal junction<br />

zone from a skin biopsy . Molecular-genetic diagnostics <strong>of</strong> EB was initiated<br />

in 2004 .<br />

Dystrophic EB (EBD) is caused by mutations in the collagen type VII<br />

(COL7A1), which consists <strong>of</strong> 118 exons . EB simplex (EBS) is caused<br />

by mutations in the keratin 5 (KRT5), which consists <strong>of</strong> 9 exons and<br />

keratin 14 (KRT14), which consists <strong>of</strong> 8 exons .<br />

DNA from EB patients and their relatives were screened for mutations<br />

in COL7A1, KRT5 and KRT14 genes . Analysis was performed using<br />

PCR, denaturing high performance liquid chromatography, high resolution<br />

melting analysis and direct sequencing . We could identify KRT5<br />

or KRT14 dominant mutations in 11 out <strong>of</strong> 18 EBS families . As regards<br />

27 EBD probands, we revealed disease causative mutations in 16 patients<br />

and screening <strong>of</strong> COL7A1 is in progress . Prenatal diagnosis <strong>of</strong><br />

one pregnancy in family with occurrence <strong>of</strong> EBS predicted the fetus<br />

being normal and subsequently a healthy child was born .<br />

Determination <strong>of</strong> EB at the level <strong>of</strong> DNA has important implication for<br />

final confirmation <strong>of</strong> diagnosis, possibility <strong>of</strong> genetic counselling and<br />

early prenatal diagnosis .<br />

This work was supported by IGA MH NR9346-3 .<br />

P05.039<br />

Erythropoietic protoporphyria in a czech family caused by a new<br />

84G>A (W28X) mutation in the ferrochelatase gene<br />

J. Prochazkova1 , J. Sperl2 , S. M. Farrag1 , L. Barnincova1 , J. Spicak2 , P. Martasek1<br />

;<br />

1 2 1st School <strong>of</strong> Medicine, Charles University, Prague, Czech Republic, Institute<br />

for Clinical and Experimental Medicine, Prague, Czech Republic.<br />

Erythropoietic protoporphyria (EPP) is a disorder with autosomal dominant<br />

inheritance caused by partial deficiency <strong>of</strong> ferrochelatase (FECH).<br />

Ferrochelatase is the ultimate enzyme <strong>of</strong> heme biosynthesis . EPP is<br />

characterized by excess accumulation <strong>of</strong> protoporphyrin, particularly

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!